288 related articles for article (PubMed ID: 22923784)
1. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening.
Krausz E; de Hoogt R; Gustin E; Cornelissen F; Grand-Perret T; Janssen L; Vloemans N; Wuyts D; Frans S; Axel A; Peeters PJ; Hall B; Cik M
J Biomol Screen; 2013 Jan; 18(1):54-66. PubMed ID: 22923784
[TBL] [Abstract][Full Text] [Related]
2. An HTS-compatible 3D colony formation assay to identify tumor-specific chemotherapeutics.
Horman SR; To J; Orth AP
J Biomol Screen; 2013 Dec; 18(10):1298-308. PubMed ID: 23918920
[TBL] [Abstract][Full Text] [Related]
3. A method for measurement of drug sensitivity of myeloma cells co-cultured with bone marrow stromal cells.
Misund K; Baranowska KA; Holien T; Rampa C; Klein DC; Børset M; Waage A; Sundan A
J Biomol Screen; 2013 Jul; 18(6):637-46. PubMed ID: 23446700
[TBL] [Abstract][Full Text] [Related]
4. Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.
Mosaad E; Chambers K; Futrega K; Clements J; Doran MR
BMC Cancer; 2018 May; 18(1):592. PubMed ID: 29793440
[TBL] [Abstract][Full Text] [Related]
5. High content screening of defined chemical libraries using normal and glioma-derived neural stem cell lines.
Danovi D; Folarin AA; Baranowski B; Pollard SM
Methods Enzymol; 2012; 506():311-29. PubMed ID: 22341231
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
7. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues.
Drewitz M; Helbling M; Fried N; Bieri M; Moritz W; Lichtenberg J; Kelm JM
Biotechnol J; 2011 Dec; 6(12):1488-96. PubMed ID: 22102438
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells.
Ramasamy K; Khatun H; Macpherson L; Caley MP; Sturge J; Mufti GJ; Schey SA; Calle Y
Br J Haematol; 2012 Jun; 157(5):564-79. PubMed ID: 22428569
[TBL] [Abstract][Full Text] [Related]
9. Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read-outs.
Santo VE; Rebelo SP; Estrada MF; Alves PM; Boghaert E; Brito C
Biotechnol J; 2017 Jan; 12(1):. PubMed ID: 27966285
[TBL] [Abstract][Full Text] [Related]
10. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
[TBL] [Abstract][Full Text] [Related]
11. Development of a high-content screening assay panel to accelerate mechanism of action studies for oncology research.
Towne DL; Nicholl EE; Comess KM; Galasinski SC; Hajduk PJ; Abraham VC
J Biomol Screen; 2012 Sep; 17(8):1005-17. PubMed ID: 22706350
[TBL] [Abstract][Full Text] [Related]
12. Microbioreactors for high-throughput cytotoxicity assays.
Yang ST; Zhang X; Wen Y
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):111-27. PubMed ID: 18175274
[TBL] [Abstract][Full Text] [Related]
13. Image-based high-throughput screening for inhibitors of angiogenesis.
Evensen L; Link W; Lorens JB
Methods Mol Biol; 2013; 931():139-51. PubMed ID: 23027002
[TBL] [Abstract][Full Text] [Related]
14. High-throughput imaging: Focusing in on drug discovery in 3D.
Li L; Zhou Q; Voss TC; Quick KL; LaBarbera DV
Methods; 2016 Mar; 96():97-102. PubMed ID: 26608110
[TBL] [Abstract][Full Text] [Related]
15. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
Evensen L; Micklem DR; Link W; Lorens JB
Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiologically relevant in vitro tumor models for drug screening.
Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
[TBL] [Abstract][Full Text] [Related]
17. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
Meier-Hubberten JC; Sanderson MP
Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
[TBL] [Abstract][Full Text] [Related]
18. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
19. [Development of fluorescence imaging based assay for screening compounds with anti-migration activity].
Nie XJ; Zhao XP; Wang Y
Yao Xue Xue Bao; 2011 Jul; 46(7):793-7. PubMed ID: 22010348
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Phenotypic Image Analysis of Three-Dimensional Organotypic Cultures.
Åkerfelt M; Toriseva M; Nees M
Methods Mol Biol; 2017; 1612():433-445. PubMed ID: 28634961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
